Japan Cancer Immunotherapy Drug Discovery Outsourcing Market (2025-2031) | Companies, Forecast, Value, Trends, Growth, Analysis, Share, Competitive Landscape, Segmentation, Industry, Size & Revenue, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F

3.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market - Industry Life Cycle

3.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market - Porter's Five Forces

3.5 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Service Type, 2021 & 2031F

3.6 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Japan

4.2.2 Growing adoption of immunotherapy for cancer treatment

4.2.3 Government initiatives and funding to support cancer research and drug discovery

4.3 Market Restraints

4.3.1 Stringent regulations and compliance requirements in drug discovery

4.3.2 High cost associated with outsourcing drug discovery services

4.3.3 Limited availability of skilled professionals in the field of immunotherapy drug discovery

6.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type

6.1.1 Overview and Analysis

6.1.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Service Type, 2021- 2031F

6.1.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Validation, 2021- 2031F

6.1.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lead Screening and Characterization, 2021- 2031F

6.1.5 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cell-based Assays, 2021- 2031F

6.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lung, 2021- 2031F

6.2.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Breast, 2021- 2031F

6.2.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Colorectal, 2021- 2031F

6.2.5 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Melanoma, 2021- 2031F

6.2.6 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Prostate, 2021- 2031F

6.2.7 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Head and Neck, 2021- 2031F

6.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type

6.3.1 Overview and Analysis

6.3.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F

6.3.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Immunomodulators, 2021- 2031F

6.3.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cancer Vaccines and Oncolytic Viral Therapy, 2021- 2031F

7.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Export to Major Countries

7.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Imports from Major Countries

8.1 Number of new cancer immunotherapy drugs in the discovery pipeline

8.2 Percentage increase in research and development (RD) spending in cancer immunotherapy

8.3 Number of partnerships and collaborations between pharmaceutical companies and outsourcing firms in Japan

8.4 Average time taken for drug discovery and development process

8.5 Number of patents filed for cancer immunotherapy drugs in Japan

9.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Service Type, 2021 & 2031F

9.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024

10.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters